Loading…
← CockpitCompetitor Analysis › 300082.SZ Liaoning Oxiranchem,Inc. Class AOpen in the cockpit ↗

Liaoning Oxiranchem,Inc. Class A300082.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Major Diversified
Momentum weak 37
Mkt cap
$673M
US dollars, full cap
Free float
47%
of shares outstanding
$/day
$6.87M
20-day average traded
Fwd P/E
33.0×
forward earnings
ROIC−WACC
-5.7 pp
WACC 8.4%
Hurdle
n/a
no reverse DCF
Next earnings
160 days
27 Apr 2027
Close · CNYCN¥6.62
1D-1.6%
1W-7.3%
1M-7.4%
3M-12.1%
6M-44.5%
YTD-33.1%
1Y-21.5%
ATR %4.0%
52w lowhigh54.0% off high

What Liaoning Oxiranchem,Inc does

Employees: 1,362

Liaoning Oxiranchem,Inc at a glance

Size Liaoning Oxiranchem,Inc (300082.SZ) is a China Materials company (Chemicals: Major Diversified) with a market value of $673M, the 2980th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥6.62 on 18 Nov 2026.

Performance Over six months the shares fell 44.5%, against -19.9% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.

Growth Revenue grew 4.3% over the last twelve months (peer median +8.3%); the operating margin is 0.4% (peer median 7.5%).

Valuation It trades at 33.0× forward earnings against a peer median of 18.6× (5th most expensive of 14).

Capital Return on invested capital runs 5.7 points below its cost of capital (8.4% WACC).

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 79300082.SZ 54
Six months, rebased to 100: Liaoning Oxiranchem,Inc against the median of its 20 peers (local-currency closes).

Liaoning Oxiranchem,Inc financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.60BCN¥4.22BCN¥4.27BCN¥3.79BCN¥5.62B
Revenue growth—-1%+13%-33%—
Gross profitCN¥400MCN¥169MCN¥71.2M-CN¥98.4MCN¥204M
EBITDAn/aCN¥168MCN¥84.4MCN¥4.73MCN¥314M
Net incomeCN¥106MCN¥6.80M-CN¥159M-CN¥309MCN¥5.60M
Free cash flow-CN¥107M-CN¥486M-CN¥65.9MCN¥20.3MCN¥51.5M
Capital expenditureCN¥32.5MCN¥20.6MCN¥28.2MCN¥70.0MCN¥258M
Total debtCN¥2.00BCN¥1.97BCN¥1.85BCN¥1.61BCN¥1.53B

Quarterly statements and history in the cockpit →

Liaoning Oxiranchem,Inc competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%002274300530000635688237300121301206523460536641894975600165603285688750603004300801301393ACI4471603155300537300082.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Liaoning Oxiranchem,Inc is the large dot.

Fundamentals: revenue growth against valuation

0%+20%0×100×200×00227468823730012160536641894975603004301393ACI603155300537300082.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Liaoning Oxiranchem,Inc is the large dot.

Liaoning Oxiranchem,Inc competitors and peer comparison

How Liaoning Oxiranchem,Inc compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Liaoning Oxiranchem,Inc against its 20 peers (data as of 18 Nov 2026)
Measure300082.SZPeer medianRank in peer set
1-month return-7.4%-12.1%8th highest of 21
6-month return-44.5%-19.9%3rd lowest of 21
Distance from 52-week high-54.0%-38.9%4th lowest of 21
Revenue growth (TTM)+4.3%+8.3%7th lowest of 21
Operating margin0.4%7.5%6th lowest of 21
Forward P/E33.0×18.6×5th most expensive of 14
ROIC minus cost of capital-5.7 pp-3.1 pp7th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Liaoning Oxiranchem,Inc 300082.SZChina$673M-45%+4%0%33.0×n/an/a
Jiansu Huachang Chemical 002274.SZChina$663M-25%+9%-3%5.6×23.2%+1.3%
Hunan Lead Power Technology 300530.SZChina$691M+12%+16%-61%n/an/an/a
Ningxia Yinglite Chemicals 000635.SZChina$650M+35%-14%-48%n/an/an/a
Hubei Chaozhuo Aviation Technology 688237.SSChina$697M-5%-1%1%37.3×43.1%+26.0%
Shandong Yanggu Huatai Chemical 300121.SZChina$703M-16%+11%8%17.5×4.7%+12.1%
Shandong Sanyuan Biotechnology 301206.SZChina$644M-21%+15%4%n/an/an/a
Daxin Materials 5234.TWTaiwan$705M-39%+12%20%15.8×15.9%+1.5%
Jiangxi Hungpai New Material 605366.SSChina$736M-46%+9%-11%211.7×n/an/a
KH Neochem 4189.TJapan$738M+20%-6%12%11.8×-5.0%+8.3%
JCU 4975.TJapan$744M-34%+5%39%13.4×5.5%+7.0%
Ningxia Zhongke Biotechnology 600165.SSChina$601M-17%+8%-73%n/an/an/a
Shandong Jianbang New Material 603285.SSChina$594M-50%+8%22%n/an/an/a
Hunan Xiangtou Goldsky Titanium Industry Technology 688750.SSChina$585M-29%+4%6%n/a28.9%-4.3%
Zhejiang Dragon Technology 603004.SSChina$582M-22%-11%16%18.6×15.8%+1.7%
Shandong Taihe Technologies 300801.SZChina$582M-42%-2%7%n/a5.2%+12.9%
Suzhou Highfine Biotech 301393.SZChina$786M-15%+36%17%29.4×n/an/a
Archean Chemical Industries ACI.NSIndia$576M-19%+6%12%31.5×n/an/a
Sanyo Chemical Industries 4471.TJapan$794M+8%+8%11%9.6×-7.2%-2.5%
Xinyaqiang Silicon Chemistry 603155.SSChina$798M-15%+25%12%37.4×22.5%+3.9%
Jiangsu Kuangshun Photosensitivity New Material Stock 300537.SZChina$568M-33%+15%6%130.1×41.7%-8.5%

Questions

Which companies are Liaoning Oxiranchem,Inc's closest peers?
The cockpit's peer set: Jiansu Huachang Chemical (002274.SZ), Hunan Lead Power Technology (300530.SZ), Ningxia Yinglite Chemicals (000635.SZ), Hubei Chaozhuo Aviation Technology (688237.SS), Shandong Yanggu Huatai Chemical (300121.SZ), Shandong Sanyuan Biotechnology (301206.SZ), Daxin Materials (5234.TW), Jiangxi Hungpai New Material (605366.SS).
Is Liaoning Oxiranchem,Inc expensive compared with its peers?
On forward p/e it trades at 33.0× against a peer median of 18.6×, 5th most expensive of 14 in its peer set.
How has Liaoning Oxiranchem,Inc stock performed?
Over six months to 18 Nov 2026 the shares returned -44.5% against -19.9% for the median peer; over one year -21.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.